IL10 and neoplasm: However, Tumor cells evade immunity through the expression of programmed cell death ligand (pdl-1) and similar inhibitory gene products, such as indoleamine 2 and 3 dioxygenase (Ido), transforming growth factor-β (TGF-β) and interleukin-10 (IL-10) (9).